INTRODUCTION
In the past few decades, the prevalence of fungal disease has increased. Multiple medically important respiratory fungal infections begin with the inhalation of the infectious propagule into the lungs where, in immunocompetent individuals, the fungus is often cleared or controlled by the host's immune system. 1 However, infection with several fungal pathogens, including Histoplasma capsulatum, Blastomyces dermatitidis, and Cryptococcus neoformans, can cause potentially fatal disease in immunocompromised individuals, including those with AIDS and those undergoing immunosuppressive therapies. [2] [3] [4] [5] Therefore, the ability of the host's immune system to eradicate or limit the spread of fungal pathogens from the lungs is vitally important.
Macrophages are innate immune cells that have critical roles in protection against pulmonary fungal pathogens, including C. neoformans, Aspergillus fumigatus, Pneumocystis, B. dermatitidis, and Paracoccidioides brasiliensis. [6] [7] [8] [9] [10] [11] [12] [13] Although patients infected with what are classically considered opportunistic infections, such as C. neoformans, A. fumigatus, and Pneumocystis, rely more heavily on innate immunity when they are T celll deficient, studies suggest that protective responses against the primary pulmonary fungal pathogens in immunocompetent individuals also depend on innate immunity. 14 Macrophages are a unique cell type as they can differentiate into multiple phenotypes with different roles: wound healing, immune regulation, and host defense. 15, 16 The purpose of this review is to demonstrate the critical role classically and alternatively activated macrophages have during respiratory fungal infections and how the outcome of infection can be determined by the macrophages' ability to polarize in a way that supports resolution and not exacerbation of disease.
DEC205 and Siglec-F; however, these markers are not exclusive to macrophages and have not been detected on macrophages from other tissues. [19] [20] [21] (An in-depth discussion of the characteristics and plasticity of alveolar macrophages is reviewed elsewhere. 19 ) Infiltrating macrophages express high levels of CD11b and Ly6C, are F4/80 þ /CD11c À , and produce pro-inflammatory cytokines, such as tumor necrosis factor-a (TNF-a) and interferon-g (IFN-g). 22, 23 Recent fate mapping studies have revealed that tissue-resident lung macrophages and other tissue-resident macrophages, including liver Kupffer cells, splenic, and peritoneal macrophages, have origins established before the birth of the organism. 24 Tissue-resident lung macrophages do appear to be of mixed origin. For example, F4/80 hi macrophages, which have a gene signature common to yolk sac macrophages, can persist in adult mice independently of hematopoietic stem cells and transcription factor Myb; however, CD11b hi /F4/80 lo and some F4/80 hi macrophages are continuously replaced by Myb-dependent bone marrow precursors. 25 A variety of tissue-resident macrophages, including microglia, lung, and peritoneal macrophages, have been shown to self-renew throughout the adult life of mice during steady state in a macrophage colony-stimulating factor (M-CSF/CSF-1) and granulocyte-macrophage (GM)-CSF (CSF-2)-dependent manner. 26 Following the release of cytokines by resident alveolar macrophages, circulating mononuclear phagocytes infiltrate into the lungs. 27 Recruited monocytes are generally divided into two main subsets: Ly6C hi /CC-chemokine receptor 2 (CCR2) þ and Ly6C lo /CX3C-chemokine receptor 1 (CX3CR1) hi (reviewed in Mosser and Edwards, 15 Shi and Pamer, 23 and Gordon and Taylor 28 ). CCR2, macrophage chemoattractant protein-1 (MCP-1)/CCL2, and MCP-3/CCL7 are critical for the egress of monocytes from the bone marrow and maintenance of normal blood monocyte counts during steady state and infection. [29] [30] [31] Deficiency of CCR2 in mice during pulmonary infection with C. neoformans results in decreased monocyte recruitment and subsequent differentiation into macrophages in the lungs and the development of a non-protective Th2-type immune response in the chronic infection model, thereby demonstrating the importance of infiltrating monocytes/ macrophages for protection. 32 In a disease setting, it is difficult to distinguish between tissue-resident lung macrophages and infiltrating macrophages; therefore further study is necessary to effectively differentiate between these subsets of macrophages. Determination of the roles played by each subset during the stages of a protective immune response, including the initiation of inflammation and the return to steady state, could facilitate the development of novel therapies that take advantage of the intrinsic roles of these cells.
MACROPHAGE ACTIVATION
Alveolar and infiltrating macrophages are able to phagocytize and kill invading pathogens and present antigen to activated T cells to further stimulate an adaptive immune response in immunocompetent individuals. A primary role of macrophages is to clear the cellular debris generated during tissue remodeling and apoptosis. During these activities, macrophages can detect danger signals through their pattern-recognition receptors, such as Toll-like receptors (TLRs) and C-type lectin receptors (CLRs). These danger signals include pathogen-associated molecular patterns on the invading organisms and damageassociated molecular patterns, which occur as the infection progresses and cells are damaged. 14, 33, 34 Macrophages have a plasticity that allows them to respond to changes in their microenvironment by altering their activation phenotype resulting in the broad classification of classical (M1) or alternative (M2) macrophage activation. 15, 35, 36 Following TLR and CLR recognition of invading microorganisms, immune cells respond by secreting inflammatory cytokines, including IFN-g, resulting in macrophage polarization toward an M1 phenotype (Figure 1) . 15, 16, 19, 37 Macrophage activation phenotypes are identified by hallmark markers, including cytokines and chemokines secreted by the activated macrophages that can induce leukocyte recruitment and aid in the resolution of infection. 15, 16 Many M1 markers are induced/upregulated by IFN-g, which is secreted by innate and adaptive immune cells, including natural killer (NK) cells, CD8 þ T cells, and CD4 þ T helper type 1 (Th1)-type T cells. 15 Monocytes/macrophages stimulated with IFN-g and lipopolysaccharide or lipopolysaccharide alone in humans or IL-12 and IL-18 in mice are subsequently capable of producing IFN-g. 38, 39 Studies in our laboratory examining M1-polarized macrophages have also led to the observation of IFN-g gene expression in murine lung macrophages during anti-cryptococcal immune responses. 6 The markers commonly used for identification of M1 macrophages include inducible nitric oxide synthase (iNOS) or nitric oxide synthase 2, chemokine (C-X-C motif) ligand 9 (CXCL9), CXCL10, CXCL11, IL-12, and suppressor of cytokine signaling 3 (SOCS3). 15, 40 CXCL9, CXCL10, and CXCL11 are chemokines that bind to a common receptor, CXCR3, and this binding results in leukocyte trafficking of principally CD4 þ Th1-type T cells, CD8 þ T cells, and NK cells. 41 SOCS3 restricts responsiveness to IL-4, resulting in downregulation of M2 macrophage activation markers, and promotes pro-inflammatory responses. 42, 43 M1 macrophages mediate host defense against foreign pathogens by microbicidal activity, including the generation of reactive oxygen and nitrogen species (ROS and RNS, respectively). 44 The enzyme iNOS acts on the substrate L-arginine to produce nitric oxide (NO), which has anti-bacterial and antifungal properties. Molecules common to fungal organismsb-glucan in fungal cell walls and zymosan, a b-glucan-rich cell wall particle prepared from Saccharomyces cerevisiae-can stimulate the production of ROS in macrophages via Dectin-1, a CLR that recognizes b-glucans, with and without the collaboration of TLRs. 45, 46 Dectin-1, along with Dectin-2, a CLR capable of a-mannan recognition, helps mediate protection against multiple fungal infections, including Coccidioides, 47, 48 Pneumocystis, 49 and Candida. 45, 50 These receptors are found on various immune cells, including monocytes/macrophages, and are important for the recognition of fungal pathogens. 46, 48, 50, 51 Recognition of fungi by Dectin-1 on macrophages leads to Dectin-1-dependent ROS production, 46 and Dectin-2 is linked to the promotion of protective Th17 cytokine responses against Candida. 50, 52 (The complex roles of Th17 immunity and Dectin-1/Dectin-2 have been reviewed elsewhere. 14, [53] [54] [55] [56] [57] [58] [59] During the damage response, anti-inflammatory cytokines, including IL-4 and IL-13, increase, and this increase induces the polarization of macrophages toward an M2 phenotype ( Figure 1 ). 15, 58, 60 M2 macrophages contribute to the suppression/regulation of inflammatory responses and have a pivotal role in wound healing. 15, 37, 40, 58 M2 macrophages have been further subcategorized into three functional categories. 15, 16 Macrophages activated by IL-4 or IL-13 are termed M2a macrophages, which secrete components of the extracellular matrix that are important for wound healing; exposure to immune complexes and IL-1R or TLR agonists induces M2b macrophages, which exert immune-regulatory functions and, along with M2a macrophages, drive Th2-type responses; and M2c macrophages are induced by IL-10 and glucocorticoid hormones and have roles in immune-regulation and tissue remodeling. 15, 16 A recent review by Martinez and Gordon 61 proposes that macrophages do not form stable subsets but instead respond to a combination of factors present in tissues where different cellular pathways interact forming complex phenotypes. Thus, the traditional M1/M2 paradigm needs to be reassessed to better understand the complexities of macrophage activation. The current review focuses on M1 macrophages and M2a macrophages, both of which are associated with antifungal responses 6,62 (Figure 1 ). IL-4 and IL-13 are secreted by immune cells, such as Th2-type CD4 þ T cells, basophils, eosinophils, and mast cells. 37, 40 These cytokines can affect macrophages by inhibiting autophagy, hampering NO production, increasing arginase activity, and deterring macrophagemediated pathogen killing. 37 Other sources of IL-13 include the group 2 innate lymphoid cells (ILCs; ILC2s), which aid in the promotion of Th2-type immune responses. 63, 64 Recent studies showed that exposure of epithelial cells to chitin, an integral part of the cell wall of numerous fungi, led to the production of IL-25, IL-33, and thymic stromal lymphopoietin. 65 In response to these cytokines, ILC2s expressed IL-5 and IL-13 resulting in increased eosinophil and M2a macrophages. 65 Chitin also triggers IL-4 expression by innate immune cells such as eosinophils and basophils, leading to induction of M2 macrophages. 65, 66 Stimulation with IL-4 induces the expression of mediators used for tissue remodeling, fibroblast accumulation, and collagen deposition-components which are important for wound healing, but do not generally assist in antimicrobial activities. 15, 16, 37, 40 The expression of IL-4 results in increased expression of mannose receptor (MR or CD206), the first described M2 macrophage activation-associated marker. 67 Historically, the general markers of M2 macrophage activation include arginase1 (Arg1), found in inflammatory zone 1 (FIZZ-1, also known as resistin-like a or Relm-a), and chitinase and chitinase-like molecules, such as YM1 (Chi3l3) and YM2. 15, 40 Arg1 has a role in the production of polyamines and prolines, which control cell proliferation and collagen production, respectively, thus indicating the essential role of M2 macrophages 
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MucosalImmunology | VOLUME 7 NUMBER 5 | SEPTEMBER 2014 in tissue remodeling and wound healing. 68, 69 FIZZ-1 is not only expressed by M2 macrophages but is also highly induced in type II alveolar epithelial cells when stimulated by Th2-associated cytokines IL-4 and IL-13, and it is associated with the pathogenesis of lung fibrosis. 70 Therefore, when evaluating FIZZ-1 and the expression of other M2 macrophage markers in vivo, it is critical to identify the source. Chitinase-like molecules YM1 and YM2 are produced in murine lungs during Th2-type immune responses and are commonly observed as crystals at the site of parasitic and fungal infections. 71 Their role is not clearly understood; however, in vitro assays have revealed that YM1 and YM2 are chemotactic for eosinophils, T lymphocytes, and polymorphonuclear leukocytes. 72 Additional markers of M2 macrophage activation include tissue remodeling and immunoregulatory genes, such as matrix metalloproteinases 2 and 7, and adenosine A3 receptor. 73 Interestingly, during C. neoformans central nervous system infection, monocyte-derived macrophages, but not microglia, exhibit the M2 markers MR and YM1. 74 Macrophages have a unique plasticity that allows them to alter their phenotype depending on the cytokine microenvironment. [75] [76] [77] When polarized toward an M1 phenotype in the presence of IFN-g, macrophages can re-polarize to an M2 phenotype when stimulated with IL-4. Similarly, M2-polarized macrophages can re-polarize toward a functional M1 phenotype in the presence of IFN-g, 75, 77, 78 signifying the critical importance of the local cytokine milieu in driving macrophage polarization. IL-4 and IFN-g have been shown to cross-regulate each other as conditions conducive to IFN-g production inhibit IL-4 production. 79 IFN-g production by Th1-type T cells and NK cells can stimulate M1 macrophage activation in a signal transducer and activator of transcription (STAT) 1-dependent manner. 80 IL-4 and/or IL-13 induces M2 macrophage activation by stimulating the STAT6 pathway. 65, 70, [81] [82] [83] One of the most commonly used markers for M2 macrophage activation, Arg1, is considered a context-dependent marker as it can be induced by STAT6 as well as STAT3, which has been associated with regulating M2 macrophage polarization. [84] [85] [86] Arg1 competes with iNOS for the substrate L-arginine and produces L-ornithine and urea while iNOS and L-arginine yield NO and citrulline. 87 The Arg1-to-iNOS ratio is often considered an indicator of macrophage polarization phenotype; however, the regulatory network in vivo has proven to be quite complex. 58 Depletion of L-arginine in peritoneal-derived macrophages pretreated with IL-4 in vitro prevents the enzymatic activity of iNOS to produce NO; however, this inhibition of NO production can be overcome by adding supplementary L-arginine. 88, 89 Therefore, conditions conducive to the induction of alternatively activated macrophages can inhibit classical macrophage activation. 90 Fungal pathogens, such as C. neoformans, 7,74,91-93 H. capsulatum, 94 P. brasiliensis, 95, 96 Coccidioides immitis, 97 C. albicans, 98 and B. dermatitidis, 99 are sensitive to the NO produced by M1 macrophages. However, many fungi use various mechanisms to avoid being killed by NO. 100, 101 In the case of H. capsulatum, macrophages can efficiently phagocytize the fungus but are unable to kill it until activated by cytokines produced by activated T cells. 102,103 P. brasiliensis is capable of inhibiting macrophage NO production by an unknown mechanism, resulting in deficient killing of the fungus. 99, 104, 105 B. dermatitidis is believed to directly inhibit the enzyme iNOS, thus preventing NO production by macrophages. 99 Coccidioides has the ability to suppress NO production; however, NO does not seem to be required for clearance, indicating that there is another mechanism important for host defense. 106, 107 C. albicans and C. neoformans are also thought to mediate NO suppression by downregulation of macrophage iNOS RNA. 108, 109 In C. albicans, deletion of the gene CaYHB1 results in decreased virulence due to NO sensitivity, nevertheless, mice still succumb to systemic infection, 98 indicating that killing by RNS may not be critical to protection against systemic C. albicans infections. Conversely, inhibition of iNOS by C. neoformans results in M2 macrophage activation and progression of disease, 7,110-113 thus, avoiding M1 macrophage activation altogether. Pneumocystis can inhibit functional NO by preventing iNOS from forming a homodimer that is required for NO production. 114, 115 In contrast to other fungal pathogens, Pneumocystis can be cleared by the activation of M2 macrophages. 62, 114 The subsequent sections of this review focus on macrophage polarization during fungal infections, principally C. neoformans and Pneumocystis species, as the majority of research in this area has been done with these prototypical model yeasts.
''CLASSICAL'' WARRIORS IN HOST DEFENSE
A number of fungal respiratory pathogens enter the host via inhalation of the infectious propagule from the environment into the lung alveoli. Here the organisms are capable of proliferation and often disseminate to other organs, particularly when the host's immune system is incapable of curtailing the infection. C. neoformans is a model organism for the study of protective M1 macrophages and associated Th1-type immune responses that aid in resolution of disease. C. neoformans has been traditionally viewed as an opportunistic pathogen that causes disease predominantly in immunocompromised individuals, such as AIDS patients. 116, 117 C. neoformans is generally inhaled by the host and, in healthy individuals, the yeast can be cleared. Conversely, in immunocompromised individuals and in some otherwise healthy individuals with no discernable underlying condition, the cryptococci can disseminate to the central nervous system, resulting in potentially fatal meningoencephalitis. Alveolar macrophages are generally one of the first cell types to encounter C. neoformans, and the interactions between these immune cells and the yeast can determine the outcome of the infection. 118, 119 Protection against C. neoformans is largely mediated by Th1-type cell-mediated immune responses which are characterized by cytokines including IFN-g, TNF-a, IL-2, and IL-12. 91, 110, [120] [121] [122] [123] [124] [125] [126] These conditions promote M1 macrophage activation and production of NO and other antimicrobial factors. Yet, infection with C. neoformans, including the highly virulent strain H99, results in Th2-type-polarized cytokine responses; production of IL-4, IL-5, and IL-13; and M2 macrophage activation. 91, 92, 112, [127] [128] [129] These macrophages are able to easily phagocytize the cryptococci but are not efficient killers of the yeast. 6, 7, 111, 130 C. neoformans cells can survive within M2 macrophages and use them as a protective niche to evade recognition and killing by the host. 131 To illustrate, IFNg À / À mice given an experimental pulmonary infection with C. neoformans have a propensity to gravitate towards an M2 phenotype and generate a Th2-type cytokine environment within the lungs, correlating with increased intracellular fungal growth within macrophages and more severe pulmonary infection ( Table 1) . 110, 111 Conversely, when infected with C. neoformans, IL-4 À / À mice have a reduced fungal burden within host macrophages and a decrease in markers for M2 activation. 111 Furthermore, mice with macrophage-specific ablation of IL-4Ra have a significantly increased survival rate and decreased pulmonary fungal burden as compared with that of wild-type (WT) mice. 132 These conditional knockout (KO) mice also have an increase in iNOS and a decrease in Arg1, YM1, and MR in pulmonary tissue as compared with what occurs with WT mice. 132 This further demonstrates the role of IL-4 in inhibition of M1 macrophage-polarizing conditions during C. neoformans infection. Experimental pulmonary infection with C. neoformans strain 52D results in a chronic infection in C57BL/6 mice, but the infection is eventually resolved in BALB/c mice. 111, 133 Inoculation with C. neoformans strain 52D in the chronic model with C57BL/6 mice results in a dynamic shift from Th2-to Th1-type cytokine production at 5 weeks after inoculation. This shift surprisingly does not aid in fungal clearance, suggesting that the initial Th2-type cytokine response allows for the establishment of a chronic fungal infection, which is not overcome by subsequent increases in IFN-g and TNF-a. 111 Additionally, deletion of the M2-polarizing cytokine IL-13 results in decreased expression of M2 macrophage activation markers, less lung eosinophilia, reduced production of Th2-type polarizing cytokines, and increased survival as compared with infected WT mice and IL-13overexpressing transgenic mice ( Table 1) . 91 Taken together, both IL-4 and IL-13 facilitate M2 macrophage polarization during infection with C. neoformans, resulting in a defective anti-cryptococcal immune response.
The role of TLRs in cryptococcal infection is controversial as studies have demonstrated conflicting data regarding the necessity of TLRs, such as TLR2 and TLR4. TLR2 recognizes a wide range of bacterial, fungal, and viral pathogen-associated molecular patterns, including lipopeptides, peptidoglycan, zymosan, and hemagglutinin. 34 TLR4 primarily recognizes bacterial lipopolysaccharide, fungal o-linked mannans, and glucuronoxylomannan. 134 Both of these TLRs signal through the TIR (Toll/IL-1 receptor) domain-containing adaptor molecule MyD88 (myeloid differentiation primary response gene 88)-dependent pathway, which drives the induction of inflammatory cytokines. 34 Macrophages with deficient TLR2 expression or MyD88 ablation exhibit reduced production of TNF-a when cultured with C. neoformans in vitro. 135 Furthermore, TLR2 À / À and MyD88 À / À mice show a decreased expression of TNF-a, IFN-g, and IL-12p40 transcripts in the lungs, brain, and spleen during infection with C. neoformans, a result which may indicate that the TLR2/MyD88 pathway is important for host defense against C. neoformans infection. 135 The lack of production of these Th1-type cytokines, particularly IFN-g, could suggest a defect in M1 macrophage activation, which may explain their increased susceptibility to cryptococcal infection. Other studies have shown that these receptors may not be required or are only marginally helpful for overcoming C. neoformans infection. 136, 137 However, the consensus is that the TLR-associated adaptor protein MyD88 is important for protection not only against C. neoformans but also against other fungal pathogens. 47, 135, 137, 138 Another receptor, TLR9, has recently been implicated in M1 macrophage activation and protection in BALB/c mice inoculated with C. neoformans strain 52D. 130 TLR9 is found on the endosomal membrane within host immune cells, including dendritic cells (DCs), plasmacytoid DCs (pDCs), monocytes, and macrophages in mice and pDCs and B cells in humans. This receptor recognizes unmethylated pathogen CpG DNA following its ingestion and degradation by the phagocyte. 139, 140 TLR9 specifically interacts with cryptococcal CpG DNA in DCs, resulting in the secretion of IL-12p40 and the expression of co-stimulatory molecule CD40. 141 Cryptococcal infection in mice with TLR9 deletion leads to decreased production of M1-polarizing IFN-g and TNF-a compared with WT mice. Additionally, TLR9 À / À mice produce more of the M2-polarizing cytokine IL-4, a condition that correlates with decreased infiltration of leukocytes into the lungs and ultimately survival ( Table 1) . 130 More compelling is that TLR9 À / À mice have increased gene expression of M2 markers Arg1 and FIZZ-1 and decreased expression of iNOS at 3 weeks post-infection, 130 suggesting that cryptococcal degradation and recognition of the CpG DNA by TLR9 is necessary for protection against C. neoformans. On the contrary, scavenger receptor A (SRA or CD204) is a receptor on immune cells, including macrophages, that senses a broad range of ligands expressed by C. neoformans, [142] [143] [144] including heat-shock proteins. 145 However, SRA has not been implicated in the activation of macrophages in response to the yeast. 146 Deletion of SRA in mice leads to decreased production of Th2-type, M2 macrophage-associated cytokines IL-4 and IL-13 by pulmonary leukocytes. 147 Additionally, following inoculation with C. neoformans, SRA À / À mice have an increase in iNOS transcripts and a decrease in Arg1 transcripts within pulmonary macrophages; however, lack of SRA expression is not sufficient for macrophage fungicidal activity. 147 As infection with virulent C. neoformans strains elicit a nonprotective, Th2-type immune response, a need remained for an infection model that allowed for the study of protective anticryptococcal immune responses. Consequently, the highly virulent C. neoformans strain H99 was genetically engineered to express murine IFN-g and was designated H99g. 148 This modified strain elicits protective immune responses in BALB/c, A/Jcr, 7, 148, 149 and C129 mice (unpublished data), thus providing a model for characterizing protective immune responses against Cryptococcus (Table 1 ). Furthermore, immunization with H99g affords 100% protection against subsequent challenge with WT C. neoformans H99. 6, 148 In both primary infection with H99g and secondary C. neoformans H99 challenge of mice immunized with H99g, there is a decrease in fungal burden, an increase in survival, and an increase in M1 macrophage activation as compared with mice given a primary inoculation with the C. neoformans H99 or a pulmonary challenge with C. neoformans H99 following mock immunization with heatkilled C. neoformans H99 (HKC.n.). 6, 7, 148 Pulmonary macrophages from mice immunized with H99g (protected) and challenged with C. neoformans H99 have an increase in iNOS transcripts, an increase in NO production, and a decrease in transcripts for Arg1, YM1, FIZZ-1, and MR as compared with mice immunized with HKC.n (non-protected). 6 In addition, studies have indicated that the M1 macrophages induced by the IFN-g-producing C. neoformans strain are likely activated via STAT1 signal transduction pathways, as total STAT1 and phosphorylated STAT1 protein, along with transcripts for STAT1-regulated genes, are increased in macrophages from protectively immunized mice. 6 These findings suggest that the induction of M1 macrophages, which are associated with protective immune responses to C. neoformans, is STAT1 mediated. Thus stimulation of the STAT1 pathway could provide a novel approach to anti-cryptococcal immune therapies and may be important for other fungal infections where M1 macrophages are protective.
THE ''ALTERNATIVE'' IN HOST RESPONSES
Like C. neoformans, Pneumocystis jiroveci (formerly known as Pneumocystis carinii, which is currently the name of the Pneumocystis species used in rats while P. murina is the species used in mice) is an opportunistic fungal pathogen most commonly associated with AIDS patients. 150, 151 Infection with P. jiroveci in immunocompromised individuals can result in life-threatening pneumonia. Fortunately, the incidence of Pneumocystis pneumonia (PCP) among AIDS patients has decreased with the introduction of highly active antiretroviral therapy 152 ; nevertheless, PCP remains a concern. The mortality rate for AIDS patients at medical facilities during two retrospective studies was approximately 10-11% and is as high as 29% in one study when intensive care was required. 153, 154 The role of T cells is a debated topic. Studies have shown that CD4 þ T cells have a critical role in host defense against Pneumocystis, because depletion of CD4 þ T cells increases the susceptibility to PCP. [155] [156] [157] However, contradictory studies suggest that resolution of an infection with Pneumocystis can occur despite persistent CD4 þ lymphocyte depletion 158, 159 ; therefore, it may be inferred that other immune cells, such as macrophages, are essential for resolving PCP. Studies suggest that alveolar macrophages contribute to an effective anti-Pneumocystis host response 10, [160] [161] [162] [163] and serve as the downstream effector cell for CD4 þ T cell-dependent clearance, 164 although much of the evidence is circumstantial. Enhanced Pneumocystis pathogenesis is associated with a reduction in alveolar macrophage numbers, 165 an effect which may be due to apoptosis induced by the organism. 166 Reduction of macrophage apoptosis in rats and mice via inhibition of caspase 9 during infection with Pneumocystis is associated with decreased pulmonary fungal burden, increased phagocytosis, and host survival. 163 The improvement of disease resolution when macrophage apoptosis is prevented indicates that the presence of pulmonary macrophages and, therefore, prevention of apoptosis is critical to host defense.
The M2 macrophage phenotype is associated with the C-type lectin receptor MR, which recognizes the carbohydrate group mannose, a structural component of fungal cell walls. 167 MR has been implicated in the mediation of cytokine production, including IL-6, TNF-a, MCP-1, GM-CSF, IL-1b, IL-12, and IL-10, and is capable of recognizing numerous fungi, including C. neoformans, C. albicans, and P. jiroveci. 167 Human alveolar macrophages recognize opsonized Pneumocystis organisms largely via MR, resulting in binding and phagocytosis of the fungus. 168, 169 MR is also found on various other cell types, including DCs and, though less abundantly, M1 macrophages. In the murine model of PCP, induction of IL-1b, IL-6, and TNF-a transcripts, as well as an influx of alveolar macrophages, is associated with clearance of the organism. 170 Use of an MR-blocking ligand or siRNA silencing of MR in human macrophages in vitro promotes the release of TNF-a to unopsonized P. jiroveci, which is not released under WT conditions in response to the unopsonized fungus. 171 MR KO mice infected with Pneumocystis were no more susceptible to PCP than WT mice. 172 However, MR KO mice exhibited a greater influx of phagocytes into the lung alveoli during infection, and this increase in pulmonary infiltrates was accompanied by greater pathology, including accumulation of glycoproteins which are normally cleared by cells expressing MR ( Table 1) . 172 Taken together, MR þ macrophages recognize Pneumocystis and may aid in regulation of pro-inflammatory TNF-a and subsequent phagocyte infiltration to the lungs, thus preventing deleterious inflammatory responses during Pneumocystis infection.
Recognition of P. murina by alveolar macrophages leads to activation of Src-family tyrosine kinases (SFKs). Recently, a study by Nelson et al. 173 showed that mice deficient in the SFKs Hck, Fgr, and Lyn (termed Src triple knockout or Src TKO mice) demonstrate augmented clearance of P. murina in the mouse model of PCP (Table 1) . However, Src TKO mice had increased cytokine and chemokine levels, as well as increased inflammatory cell recruitment to the lungs. 173 In addition, the alveolar macrophages of Src TKO mice more efficiently killed P. murina as compared with macrophages from infected WT mice. 173 Further study of PCP in the Src TKO mice revealed that clearance of Pneumocystis is associated with enhanced M2a macrophage activation, as evidenced by increased levels of FIZZ-1, Arg1, and YM1 transcripts in the lungs at day 3 postinfection as compared with what occurred with WT mice. 62 In addition, while there was no increase in IL-4 and IL-13, there was an increase in IL-33, 62 which can work synergistically with IL-4 and IL-13, 174 thus suggesting that IL-33 may have a role in enhancing M2a macrophage activation during Pneumocystis infection. Other studies have indicated that IL-33 may have a role in amplifying the polarization of M2 macrophages and potentially contributes to airway inflammation. 175 Activated NK T cells are capable of inducing alveolar macrophages to produce IL-33, further activating NK T cells, as well as ILCs, to produce IL-13. 176 Intranasal administration of chitin in mice resulted in the increased expression of IL-25, IL-33, and thymic stromal lymphopoietin, resulting in the production of IL-5 and IL-13 by ILC2s as well as M2 macrophage activation. 65 The study also showed that chitin stimulation resulted in ILC2-mediated suppression of Th1-and Th17-type cytokine responses and increased eosinophil infiltration, further demonstrating a link between IL-33 and the cytokine microenvironment in the lung during fungal-induced inflammation. 65 In humans, chemoattractant receptor CRTH2 þ ILCs were shown to respond to IL-33 and IL-25 (IL-17E) by the production of IL-13. 177 Pretreatment of macrophages with recombinant IL-33 (rIL-33) and IL-13 enhanced in vitro killing of P. murina as compared with macrophages pretreated with IL-13 alone, IL-33 alone, IFN-g alone, or untreated macrophages. 62 Furthermore, intraperitoneal injections of rIL-33 in mice during infection led to a reduction in pulmonary fungal burden and to increases in markers of M2a activated macrophages and their by-products, such as CCL17/thymus and activation-regulated chemokine that can lead to recruitment of Th2-type T cells ( Table 1) . 16, 62, 178 Alternatively, IL-33 signaling has been shown to have a detrimental role during infection with C. neoformans and is upregulated during infection with the yeast. 179 Deficiency in T1/ST2, the unique IL-33R, resulted in reduced M2 activation and decreased fungal burden and dissemination of C. neoformans. The results of these studies further exemplify how infection with different fungal organisms requires variations in the host's immune response to prevent the progression of disease.
An important point to remember is that not all mouse strains produce the same results during experimental infections. A recent study examined the role of STAT4 during the protective immune response against pulmonary infection with Pneumocystis using both C57BL/6 and BALB/c mice with STAT4 deletion ( Table 1 ). STAT4 is activated by IL-12 signaling which, along with the transcription factor T-bet, is required for optimal development of Th1-type T cells. 180 STAT4 has also been shown to antagonize Th2 development. 181 C57BL/6 Stat4 À / À mice exhibited an increase in transcripts for M2 macrophage activation marker FIZZ-1 while BALB/c Stat4 À / À mice had decreased levels of FIZZ-1, and neither group of KO mice showed a difference in mRNA levels for the M1 marker iNOS as compared with WT mice. 182 Interestingly, BALB/c Stat4 À / À mice were more susceptible to PCP, suggesting that the intact M2 macrophage activation in the C57BL/6 Stat4 À / À mice may contribute to protection. 182 Overall, evidence suggests that the polarization of alveolar macrophages toward an M2 phenotype is conducive to the induction of protective immune responses against Pneumocystis. Although M2a macrophages appear capable of directly killing Pneumocystis yeasts, it may be that the anti-inflammatory environment promoted by M2a macrophages prevents the development of over-exuberant pulmonary inflammatory responses. In the mouse model of PCP, IL-33 appears to have a role in the protective immune response. Immune cells, such as macrophages and DCs, and alveolar epithelial cells have been implicated as sources of IL-33 mRNA. 62, 183 IL-33, in turn, induces the production of IL-13 by ILCs, 176 further stimulating M2 macrophages and the progression of a Th2-type immune response. The suppression of inflammatory damage during this response may be an indirect mechanism of protection; however, additional research is necessary.
FUTURE STRATEGIES TO COMBAT FUNGAL PATHOGENESIS
Many pathogens induce an environment within the host that favors their own proliferation and dissemination. A potential tactic for designing novel treatments is to develop strategies for overcoming these pathogen-mediated effects so as to induce a more microbicidal environment. Therapeutics targeting modifications of the host response rather than the pathogen would limit selective pressure on the microbe that can lead to drug resistance and increased virulence. The studies discussed in this review have indicated that macrophage polarization has a major role in the outcome of infection. Therapeutics targeting macrophage activation to shift polarization toward an antifungal phenotype may provide a novel method for treatment of fungal infections.
In the case of Pneumocystis pneumonia, treatments that reduce pulmonary inflammation and promote the polarization of macrophages toward an M2a phenotype would be beneficial in slowing and/or stopping disease progression. Macrophages treated with IL-33 and IL-13 have an increased fungicidal effect on Pneumocystis compared with M1 macrophages induced by IFN-g. 62 Intraperitoneal injection of rIL-33 in mice led to greater pulmonary clearance of the yeast, 62 indicating that IL-33 has potential as a novel immunotherapy for PCP. Additionally, sulfasalazine, a potent anti-inflammatory drug, enhances the clearance of Pneumocystis from the lung in the PCP-Immune Reconstitution Inflammatory Syndrome (IRIS) model, correlating with the promotion of M2 macrophage activation. 164 Sulfasalazine is normally used to treat inflammatory illnesses, such as Crohn's disease 184 and rheumatoid arthritis, 185 by altering macrophage and T-cell responses and inhibiting nuclear factor-kB. 186, 187 During infection with Pneumocystis, sulfasalazine treatment resulted in reduced severity of disease, decreased inflammation, and promotion of M2 macrophage activation. The M2-polarized macrophages displayed enhanced phagocytosis and clearance of the fungus, 164 further supporting a role of M2 macrophages in protection against PCP.
Skewing of the immune response and subsequent macrophage polarization phenotype is a technique a number of fungal pathogens use to aid in host invasion and colonization. Studies have shown that M2 polarization can be shifted to M1 35, 188 ; however, it is not known whether the macrophages are being re-polarized or if newly infiltrating macrophages become M1 polarized. Nevertheless, the local cytokine milieu is perhaps the final determinant of macrophage polarization phenotype. Studies examining plasticity of tumor-associated macrophages have indicated that administering IFN-g or targeting nuclear factor-kB have re-polarized M2 macrophages to M1 macrophages in vivo. 189, 190 A recent study has demonstrated that macrophages polarized toward an M2 phenotype with IL-4, as observed during infection with C. neoformans, can be overcome by the addition of IFN-g in vitro, resulting in a phenotypic switch to functional M1 macrophages. 78 These re-polarized macrophages were fully capable of producing NO and were fungicidal, thus inhibiting proliferation of the yeast. 78 Therefore, strategies for inducing M1 macrophage activation and/or inhibiting M2 macrophage activation during infection could prove to be a novel and effective method of inducing host protection against Cryptococcus and other fungal infections. For example, treatment of macrophages with kojic acid, a secondary metabolite of fungal species, including Aspergillus and Penicillium, results in increased ROS production but not NO. 191 More investigation to characterize the macrophage activation phenotype and to determine the anti-fungal activity of kojic acid is needed. Serum amyloid P has recently been shown to inhibit M2 polarization via an FcgR-dependent mechanism in cultured macrophages. 192 The effect led to the downregulation of M2 markers, a decrease in STAT6 phosphorylation, and attenuated A. fumigatus-induced allergic airway disease, 192 suggesting that inhibition of M2 polarization shows promise for treatment of Aspergillus and other pulmonary fungal infections that result in allergic airway disease. Additionally, studies in our lab have suggested that STAT1 has a role in mediating M1 macrophage activation and subsequent protection against C. neoformans 6 ; therefore, induction of the IFN-g/ STAT1 signaling pathway could provide a potential mechanism for induction of M1 macrophages.
The stimulation of M1 macrophage activation and/or the prevention of M2 macrophage activation have the potential to provide protection against a myriad of fungal infections, including C. neoformans, H. capsulatum, and A. fumigatus. Induction of pro-inflammatory responses by M1 macrophages, as well as the production of ROS and RNS, contributes to eradication of the pathogen and resolution of disease. However, induction of M2 macrophages, but not M1 macrophages, is conducive to clearance of Pneumocystis infections. Dampening of pro-inflammatory responses that limit PCP-associated damage, along with the anti-Pneumocystis activity of M2 macrophages, allows the host to resolve the infection. Therefore, discovery and utilization of therapeutics that induce polarization of macrophages toward an anti-fungal phenotype must consider the pathogen in question. Targeting the host's immune response rather than the pathogen could provide a much needed, novel approach to the treatment of fungal infections.
